We are live on ! Find out more
KA

Keene & Associates Portfolio holdings

AUM $125M
1-Year Est. Return 13.49%
This Fund
S&P 500
This Quarter Est. Return
+4.03%
1 Year Est. Return
+13.49%
3 Year Est. Return
+20.33%
5 Year Est. Return
10 Year Est. Return
AUM
$123M
AUM Growth
+$6.83M
Cap. Flow
+$5.77M
Cap. Flow %
4.71%
Top 10 Hldgs %
30.09%
Holding
83
New
2
Increased
48
Reduced
24
Closed
2

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$3.18M
2
DIS icon
Walt Disney
DIS
+$1.26M
3
BWA icon
BorgWarner
BWA
+$929K
4
MCK icon
McKesson
MCK
+$698K
5
FDX icon
FedEx
FDX
+$652K

Top Sells

Rank Stock Value
1
EXC icon
Exelon
EXC
+$3.49M
2
PEP icon
PepsiCo
PEP
+$925K
3
CVX icon
Chevron
CVX
+$857K
4
KR icon
Kroger
KR
+$680K
5
OXY icon
Occidental Petroleum
OXY
+$534K

Sector Composition

Rank Sector Weight
1 Consumer Staples 25.09%
2 Healthcare 20.88%
3 Technology 16.15%
4 Industrials 11.92%
5 Materials 9.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SYNA icon
76
Synaptics
SYNA
$4.12B
$245K 0.2%
1,228
+192
+19% +$42.6K
NG icon
77
NovaGold Resources
NG
$2.62B
$77K 0.06%
10,000
NGD
78
DELISTED
New Gold Inc
NGD
$18K 0.01%
10,000
VGZ icon
79
Vista Gold
VGZ
$260M
$15K 0.01%
14,200
TRX icon
80
TRX Gold Corp
TRX
$256M
$4K ﹤0.01%
+11,966
New +$4.42K
EXC icon
81
Exelon
EXC
$47.1B
-84,692
Closed -$3.49M
JBLU icon
82
JetBlue
JBLU
$2.35B
-11,925
Closed -$170K

Similar funds

Keene & Associates's Q1 2022 Portfolio in Review

As of Q1 2022, Keene & Associates held 83 positions worth $123M, up 5.9% from $116M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Keene & Associates deployed $5.77M of net new capital in Q1 2022, opening 2 new positions and adding to 48 existing holdings. Its largest new stake was Medtronic: 30,074 shares worth $3.34M.

By sector, the portfolio is most concentrated in Consumer Staples at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was PepsiCo, an estimated $925K trimmed.

  • Keene & Associates's largest Q1 2022 buy was Medtronic: 30,074 shares worth $3.34M.
  • Keene & Associates added most to Walt Disney in Q1 2022, an estimated $1.26M increase.
  • Keene & Associates's biggest Q1 2022 reduction was PepsiCo, cutting an estimated $925K.
  • Keene & Associates fully exited Exelon in Q1 2022, selling an estimated $3.49M.
  • Keene & Associates's ten largest holdings make up 30% of its $123M portfolio in Q1 2022.
  • Keene & Associates opened 2 new positions and closed 2 in Q1 2022.
  • Keene & Associates's portfolio value rose 5.9% quarter-over-quarter to $123M.

Based on Keene & Associates's 13F filing for Q1 2022, filed 12 Apr 2022.